Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive…